Literature DB >> 15545884

Rhabdomyolysis resulting from interaction of simvastatin and clarithromycin demonstrated by Tc-99m MDP scintigraphy.

Joseph Trieu1, Louise Emmett, Chandi Perera, Krish Thanakrishnan, Hans Van Der Wall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15545884     DOI： 10.1097/00003072-200412000-00008

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


× No keyword cloud information.
  9 in total

1.  Rhabdomyolysis caused by co-medication with simvastatin and clarithromycin.

Authors:  Judith Wagner; Christine Suessmair; Hans-Walter Pfister
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

Review 2.  Is There Potential for Repurposing Statins as Novel Antimicrobials?

Authors:  Emma Hennessy; Claire Adams; F Jerry Reen; Fergal O'Gara
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

3.  Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications.

Authors:  Jim S Wu; Catherine Buettner; Howard Smithline; Long H Ngo; Robert L Greenman
Journal:  Muscle Nerve       Date:  2011-01       Impact factor: 3.217

4.  Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4.

Authors:  Daniel Q Li; Richard Kim; Eric McArthur; Jamie L Fleet; David G Bailey; David Juurlink; Salimah Z Shariff; Tara Gomes; Muhammad Mamdani; Sonja Gandhi; Stephanie Dixon; Amit X Garg
Journal:  CMAJ       Date:  2014-12-22       Impact factor: 8.262

Review 5.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

6.  Simvastatin Improves Neutrophil Function and Clinical Outcomes in Pneumonia. A Pilot Randomized Controlled Clinical Trial.

Authors:  Elizabeth Sapey; Jaimin M Patel; Hannah Greenwood; Georgia M Walton; Frances Grudzinska; Dhruv Parekh; Rahul Y Mahida; Rachel C A Dancer; Sebastian T Lugg; Philip A Howells; Jon Hazeldine; Paul Newby; Aaron Scott; Peter Nightingale; Adam T Hill; David R Thickett
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

Review 7.  Granulocyte-targeted therapies for airway diseases.

Authors:  Luciana P Tavares; Hong Yong Peh; Wan Shun Daniel Tan; Hadas Pahima; Pasquale Maffia; Ekaterini Tiligada; Francesca Levi-Schaffer
Journal:  Pharmacol Res       Date:  2020-05-04       Impact factor: 7.658

8.  Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions.

Authors:  Jamie L Fleet; Salimah Z Shariff; David G Bailey; Sonja Gandhi; David N Juurlink; Danielle M Nash; Muhammad Mamdani; Tara Gomes; Amit M Patel; Amit X Garg
Journal:  BMJ Open       Date:  2013-07-11       Impact factor: 2.692

9.  A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.

Authors:  Bita Mesgarpour; Ghazaleh Gouya; Harald Herkner; Berthold Reichardt; Michael Wolzt
Journal:  Lipids Health Dis       Date:  2015-10-24       Impact factor: 3.876
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.